DK1845954T3 - Oralt opløsende sammensætning af olanzapin og donepzil - Google Patents
Oralt opløsende sammensætning af olanzapin og donepzilInfo
- Publication number
- DK1845954T3 DK1845954T3 DK06701464.7T DK06701464T DK1845954T3 DK 1845954 T3 DK1845954 T3 DK 1845954T3 DK 06701464 T DK06701464 T DK 06701464T DK 1845954 T3 DK1845954 T3 DK 1845954T3
- Authority
- DK
- Denmark
- Prior art keywords
- olanzapine
- donepzil
- orally dissolving
- dissolving composition
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05000664A EP1681048A1 (en) | 2005-01-14 | 2005-01-14 | Orally disintegrating composition of olanzapine or donepezil |
| PCT/EP2006/000284 WO2006074951A2 (en) | 2005-01-14 | 2006-01-13 | Orally disintegrating composition of olanzapine or donepezil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1845954T3 true DK1845954T3 (da) | 2010-08-16 |
Family
ID=34933289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06701464.7T DK1845954T3 (da) | 2005-01-14 | 2006-01-13 | Oralt opløsende sammensætning af olanzapin og donepzil |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP1681048A1 (da) |
| AT (1) | ATE465719T1 (da) |
| AU (1) | AU2006205817A1 (da) |
| DE (1) | DE602006013940D1 (da) |
| DK (1) | DK1845954T3 (da) |
| EA (1) | EA013742B1 (da) |
| ES (1) | ES2344959T3 (da) |
| HR (1) | HRP20100399T1 (da) |
| NO (1) | NO20074087L (da) |
| PL (1) | PL1845954T3 (da) |
| PT (1) | PT1845954E (da) |
| SI (1) | SI1845954T1 (da) |
| UA (1) | UA89394C2 (da) |
| WO (1) | WO2006074951A2 (da) |
| ZA (1) | ZA200706692B (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7879382B2 (en) | 2005-09-30 | 2011-02-01 | Fmc Corporation | Stabilizers and compositions and products comprising same |
| DE102005060377A1 (de) * | 2005-12-16 | 2007-06-21 | Ratiopharm Gmbh | Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung |
| JP5535616B2 (ja) | 2006-03-31 | 2014-07-02 | ルビコン リサーチ プライベート リミテッド | 口腔内崩壊錠剤のための直接圧縮性複合材 |
| GB0614586D0 (en) * | 2006-07-22 | 2006-08-30 | Pliva Istrazivacki Inst D O O | Pharmaceutical Formulation |
| PL2248519T3 (pl) | 2006-10-02 | 2018-04-30 | Apr Applied Pharma Research S.A. | Niemukoadhezyjne postaci dawkowania w postaci filmu |
| EP2076249A2 (en) * | 2006-10-27 | 2009-07-08 | FMC Corporation | Dry granulation binders, products, and use thereof |
| CN101646461A (zh) | 2007-03-13 | 2010-02-10 | 大日本住友制药株式会社 | 口腔崩解片 |
| EP2205213A2 (en) | 2007-10-01 | 2010-07-14 | Laboratorios Lesvi, S.L. | Orodispersible tablets |
| CN101756917A (zh) * | 2008-10-24 | 2010-06-30 | 北京科信必成医药科技发展有限公司 | 盐酸多奈哌齐口腔崩解片及其制备方法 |
| WO2010070611A1 (en) * | 2008-12-18 | 2010-06-24 | Ranbaxy Laboratories Limited | Atazanavir formulations |
| EP2198857A1 (en) | 2008-12-19 | 2010-06-23 | Ratiopharm GmbH | Oral dispersible tablet |
| TR200903293A1 (tr) * | 2009-04-28 | 2010-11-22 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Oral yolla dağılan olanzapin tablet. |
| TR201002084A1 (tr) * | 2010-03-19 | 2011-10-21 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi |
| FR2962331B1 (fr) * | 2010-07-06 | 2020-04-24 | Ethypharm | Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre |
| WO2012014012A1 (es) * | 2010-07-27 | 2012-02-02 | Laboratorios Andrómaco S.A. | Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia. |
| US9826763B2 (en) | 2011-10-05 | 2017-11-28 | Fmc Corporation | Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
| EP2764045B1 (en) | 2011-10-05 | 2017-03-01 | FMC Corporation | Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
| WO2013085810A2 (en) | 2011-12-09 | 2013-06-13 | Fmc Corporation | Co-attrited stabilizer composition |
| WO2014027975A2 (en) * | 2012-08-17 | 2014-02-20 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Novel orally administered pharmaceutical formulations |
| FR2999432B1 (fr) | 2012-12-17 | 2014-12-12 | Ethypharm Sa | Comprimes orodispersibles obtenus par compression moulage |
| CN104510717B (zh) * | 2013-09-27 | 2019-02-05 | 江苏豪森药业集团有限公司 | 奥氮平口崩片及其制备方法 |
| CN108261399A (zh) * | 2016-12-30 | 2018-07-10 | 江苏豪森药业集团有限公司 | 奥氮平口腔崩解片及其制备方法 |
| CN108926543A (zh) * | 2017-05-26 | 2018-12-04 | 万全万特制药江苏有限公司 | 一种奥氮平口腔崩解片及其制备方法 |
| CN109498544A (zh) * | 2017-09-15 | 2019-03-22 | 万全万特制药江苏有限公司 | 稳定的奥氮平组合物及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001064190A1 (fr) * | 2000-03-01 | 2001-09-07 | Eisai Co., Ltd. | Comprimes se desagregeant rapidement contenant du poly(alcool de vinyle) |
| AU2002255196A1 (en) * | 2002-04-18 | 2003-10-27 | Dr. Reddy's Laboratories Ltd. | Rapidly dispersing solid oral compositions |
-
2005
- 2005-01-14 EP EP05000664A patent/EP1681048A1/en not_active Withdrawn
-
2006
- 2006-01-13 SI SI200630726T patent/SI1845954T1/sl unknown
- 2006-01-13 ES ES06701464T patent/ES2344959T3/es active Active
- 2006-01-13 PL PL06701464T patent/PL1845954T3/pl unknown
- 2006-01-13 WO PCT/EP2006/000284 patent/WO2006074951A2/en active Application Filing
- 2006-01-13 UA UAA200709252A patent/UA89394C2/uk unknown
- 2006-01-13 DK DK06701464.7T patent/DK1845954T3/da active
- 2006-01-13 AU AU2006205817A patent/AU2006205817A1/en not_active Abandoned
- 2006-01-13 AT AT06701464T patent/ATE465719T1/de active
- 2006-01-13 EA EA200701462A patent/EA013742B1/ru not_active IP Right Cessation
- 2006-01-13 EP EP06701464A patent/EP1845954B1/en active Active
- 2006-01-13 PT PT06701464T patent/PT1845954E/pt unknown
- 2006-01-13 DE DE602006013940T patent/DE602006013940D1/de active Active
-
2007
- 2007-08-07 NO NO20074087A patent/NO20074087L/no not_active Application Discontinuation
- 2007-08-13 ZA ZA200706692A patent/ZA200706692B/en unknown
-
2010
- 2010-07-20 HR HR20100399T patent/HRP20100399T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20100399T1 (hr) | 2010-09-30 |
| WO2006074951A3 (en) | 2007-04-26 |
| UA89394C2 (uk) | 2010-01-25 |
| PL1845954T3 (pl) | 2010-10-29 |
| SI1845954T1 (sl) | 2010-08-31 |
| EA013742B1 (ru) | 2010-06-30 |
| WO2006074951A2 (en) | 2006-07-20 |
| EP1845954B1 (en) | 2010-04-28 |
| ES2344959T3 (es) | 2010-09-10 |
| DE602006013940D1 (de) | 2010-06-10 |
| ATE465719T1 (de) | 2010-05-15 |
| NO20074087L (no) | 2007-10-09 |
| EA200701462A1 (ru) | 2008-02-28 |
| PT1845954E (pt) | 2010-08-02 |
| AU2006205817A1 (en) | 2006-07-20 |
| EP1681048A1 (en) | 2006-07-19 |
| ZA200706692B (en) | 2008-07-30 |
| EP1845954A2 (en) | 2007-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1845954T3 (da) | Oralt opløsende sammensætning af olanzapin og donepzil | |
| TW200621313A (en) | Pharmaceutical compositions | |
| HN2012001162A (es) | Triazolopiridinas | |
| NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
| ECSP066376A (es) | FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN | |
| DK1907373T3 (da) | Fremgangsmåder til fremstillingen af 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindolin-1,3-dionforbindelser | |
| DK2024352T3 (da) | Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling | |
| DK1858342T3 (da) | Fremgangsmåde til fremstilling af ernæringssammensætninger | |
| NO20084850L (no) | MGLUR5 modulatorer I | |
| NI201100143A (es) | Composición farmacéutica sólida que comprende amlodipina y losartan. | |
| DK1695710T3 (da) | Krystallinsk betad-form af ivabradinhydrochlorid, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende denne | |
| DK1810676T3 (da) | Levetiracetam formuleringer og fremgangsmåder til deres fremstilling | |
| DK1869035T3 (da) | Hidtil ukendt krystallinsk form af tiotropiumbromid og fremgangsmåde til fremstilling deraf | |
| CR10497A (es) | Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38 | |
| HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
| EA200701687A1 (ru) | Гидрохлорид аморфного лерканидипина | |
| EA200601608A1 (ru) | Способ производства твёрдой фармацевтической композиции | |
| HN2008001393A (es) | Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
| DK1756049T3 (da) | Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater | |
| ATE429906T1 (de) | Trockene aripiprazolformulierungen | |
| BRPI0607645A2 (pt) | sais de derivados de hexaidrofenantridina substituìdos com 6-heterociclila | |
| EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
| DK1879580T3 (da) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolinderivater som lægemidler til behandling af infertilitet | |
| DK1881830T3 (da) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet | |
| MX2007011826A (es) | Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas. |